HTS plays a crucial role in the development of personalized medicine by identifying biomarkers and genetic mutations that are specific to an individual’s cancer. This enables the development of targeted therapies that are tailored to the unique genetic profile of a patient's tumor, thereby improving treatment efficacy and reducing side effects.
